| |
| >
|
Publications
- Bott C, Rudolph MW, Schirrmacher
S, Skalsky B, Petereit H-U,
Langguth P, Dressman JB, Stein
J. In vivo evaluation of a
novel pH- and time-based multi-unit
drug deilivery system. Aliment
Pharmacol Ther (submitted).
- Schröder O, Blumenstein
I, Schulte-Bockholt A, Stein
J. Combining infliximab and
methotrexate in fistulising
Crohn's disease resistant
or intolerant to azathioprine.
Aliment Pharmacol Ther 2004
Feb; 19(3): 295-301.
- Teuber G, Pascu M, Berg
T, Lafrenz M, Pausch J, Kullmann
F, Ramadori G, Arnold R, Weidenbach
H, Musch E, Junge U, Wiedmann
KH, Herrmann E, Zankel M,
Zeuzem S. Randomized, controlled
trial with IFN-alpha combined
with ribavirin with and without
amantadine sulphate in non-responders
with chronic hepatitis C.
J Hepatol 2003 Oct; 39(4):
606-13.
- Schröder O, Stein J.
Low dose methotrexate in inflammatory
bowel disease: current status
and future directions. Am
J Gastroenterol 2003 Mar;
98(3): 530-7.
- Jordan A, Stein J. Effect
of an omega-3 fatty acid containing
lipid emulsion alone and in
combination with 5-fluorouracil
(5-FU) on growth of the colon
cancer cell line Caco-2. Eur
J Nutr. 2003 Dec; 42(6): 324-31.
- Wolter F, Turchanowa L,
Stein J. Resveratrol-induced
modification of polyamine
metabolism is accompanied
by induction of c-Fos. Carcinogenesis.
2003 Mar; 24(3): 469-74.
- Trojan J, Povse N, Schröder
O, Stein J. A new immunological
test strip device for the
rapid, qualitative detection
of faecal occult blood. Z
Gastroenterol 2002 Nov; 40(11):
921-4.
- Gaschott T, Steinmeyer A,
Steinhilber D, Stein J. ZK
156718, a low calcemic, antiproliferative,
and prodifferentiating vitamin
D analog. Biochem Biophys
Res Commun. 2002 Jan 11; 290(1):
504-9.
- Wächtershauser A, Akoglu
B, Stein J. HMG-CoA reductase
inhibitor mevastatin enhances
the growth inhibitory effect
of butyrate in the colorectal
carcinoma cell line Caco-2.
Carcinogenesis. 2001 Jul;
22(7): 1061-7.
- Teuber G, Berg T, Naumann
U, Raedle J, Brinkmann S,
Hopf U, Zeuzem S. Randomized,
placebo-controlled, double-blind
trial with interferon-alpha
with and without amantadine
sulphate in primary interferon-alpha
nonresponders with chronic
hepatitis C. J Viral Hepat
2001 Jul; 8(4): 276-83.
- Gaschott T, Wächtershauser
A, Steinhilber D, Stein J.
1,25-Dihydroxycholecalciferol
enhances butyrate-induced
p21(Waf1/Cip1) expression.
Biochem Biophys Res Commun.
2001 Apr 27; 283(1): 80-5.
- Sarrazin C, Teuber G, Kokka
R, Rabenau H, Zeuzem S. Detection
of residual hepatitis C virus
RNA by transcription-mediated
amplification in patients
with complete virologic response
according to polymerase chain
reaction-based assays. Hepatology
2000 Oct; 32(4 Pt 1): 818-23.
|
|
